The CEO of Workday (NASDAQ: WDAY) is Buying Shares (Analyst Ratings)
Yesterday, the CEO of Workday (WDAY), Aneel Bhusri, bought shares of WDAY for $390K. Following Aneel Bhusri’s last WDAY Buy transaction on March 08, 2016, the stock climbed by 92.4%. This recent transaction increases Aneel Bhusri’s holding in the company by 80.13% to a total of $61.26 million.
Insider Trading: December 10, 2019 (BIV.com)
Insider Steve Evans, director. Company: American Hotel Income Properties REIT LP (TSX:HOT). Shares owned: 168,000. Trade date: November 29, December 2. Trade total: US$726,970. Trade: Acquisition of 106,400 shares at prices ranging between US$6.79 and US$6.85 per share. Insider Robin Anne Bienenstock, director. Company: Pretium Resources Inc. (TSX:PVG). Shares owned: 154,232. Trade date: November 27. Trade total: US$135,240. Trade: Acquisition of 14,000 shares at a price of US$9.66 per share.
Health Sciences Acquisitions Corp (HSAC) CEO Roderick Wong Bought $510,000 of Shares (Guru Focus)
CEO of Health Sciences Acquisitions Corp., Roderick Wong, bought 50,000 shares of HSAC on 12/06/2019 at an average price of $10.2 a share. The total cost of this purchase was $510,000. Health Sciences Acquisitions Corp has a market cap of $146.630 million; its shares were traded at around $10.20.
Why 13 Republican Representatives Voted Against Banning Insider Trading (Fortune)
Insider trading is illegal in the United States, but what that actually means is often up to interpretation. The term has never had an official statuary definition, causing prosecutors a lot of headaches as they attempt to argue cases based on court precedent instead of on a set of established standards. On Thursday, Congress attempted to amend that by officially banning-and defining-the practice.
Ex-U.S. Rep Collins, Others Settle With SEC Over Insider Trading (ThinkAdvisor)
The Securities and Exchange Commission has reached a settlement with former Rep. Christopher Collins, R-N.Y., over an insider-trading case involving an Australian biotech firm. As part of the settlement, Collins will be barred from serving as an officer or director of public companies in the future, according to the SEC. In addition, his son Cameron Collins and Stephen Zarsky (the father of Cameron’s fiancée) will pay back avoided losses and interest of nearly $800,000.
The CSO of Aevi Genomic Medicine (NASDAQ: GNMX) is Buying Shares (Analyst Ratings)
Yesterday, the CSO of Aevi Genomic Medicine (GNMX), Garry Arthur Neil, bought shares of GNMX for $266.4K. This recent transaction increases Garry Arthur Neil’s holding in the company by 1785.58% to a total of $502.1K. In addition to Garry Arthur Neil, 2 other GNMX executives reported Buy trades in the last month.
